आईएसएसएन: 2332-0877

संक्रामक रोग और थेरेपी जर्नल

खुला एक्सेस

हमारा समूह 1000 से अधिक वैज्ञानिक सोसायटी के सहयोग से हर साल संयुक्त राज्य अमेरिका, यूरोप और एशिया में 3000+ वैश्विक सम्मेलन श्रृंखला कार्यक्रम आयोजित करता है और 700+ ओपन एक्सेस जर्नल प्रकाशित करता है जिसमें 50000 से अधिक प्रतिष्ठित व्यक्तित्व, प्रतिष्ठित वैज्ञानिक संपादकीय बोर्ड के सदस्यों के रूप में शामिल होते हैं।

ओपन एक्सेस जर्नल्स को अधिक पाठक और उद्धरण मिल रहे हैं
700 जर्नल और 15,000,000 पाठक प्रत्येक जर्नल को 25,000+ पाठक मिल रहे हैं

में अनुक्रमित
  • सूचकांक कॉपरनिकस
  • गूगल ज्ञानी
  • जे गेट खोलो
  • RefSeek
  • हमदर्द विश्वविद्यालय
  • ईबीएससीओ एज़
  • ओसीएलसी- वर्ल्डकैट
  • पबलोन्स
  • यूरो पब
  • आईसीएमजेई
इस पृष्ठ को साझा करें

अमूर्त

SARS-CoV-2 Rapid Antigen Test: Laboratory Validation of the Performance of POCT Antigen Test Kits of COVID-19

Zhang Lie, Yang Feng, Zhu Junzhe

With the advent of deadly SARS-CoV-2, public health organizations and researchers emphasized the timely detection and identification of the virus to limit the spread. Different tests were designed to detect coronaviruses for timely and rapid identification, including Polymerase Chain Reaction (PCR) that detects the organism's genetic material. This research aims to validate the performance of Point-of-care testingantigen test kits of COVID-19, including the Lateral Flow Test (LFT) and the lateral Flow Immunofluorescent Assay (FIA) is intended for qualitative detection of SARS-CoV-2 nucleocapsid antigen. This evaluation involved six different rapid test kits, including Fia Test ATFNCG21040001, All Test ATNCP21060014, All Test ATNCP21060015, All Test ATNCP21060012, Abbott Panbio Cov-19 Ag Rapid Test, and Siemens Rapid COVID-19 Antigen Test. In addition, another study also compare the SARS-CoV-2 Antigen Rapid Test (COVID-19 Antigen Rapid Test) (Swab) manufactured by Hangzhou All Test Biotech Co., Ltd.; 2019-nCoV Antigen Test, manufactured by Guangzhou Wondfo Biotech Co., Ltd.; SARS-CoV-2 Rapid Antigen Test, manufactured by Roche, the molecular SARS-COV-2 assay (nucleic acid extraction using the automatic system Versant, followed by RT-PCR using the FDT SARS-CoV-2 kit) manufactured by Siemens from Germany that meets EU CE standards, to evaluate the clinical effectiveness of candidate kit. The Nasopharyngeal Swab (NPS) samples were collected and analysed by RT-PCR method. The specificity of all rapid test kits was greater than 99.9%, whereas the sensitivity ranged from 91 to >99%, which is also significant. The finding suggests the rapid antigen test can be used as an effective tool in controlling COVID-19 promptly. Moreover, these tests can also be conducted by a layman or at home for primary identification of COVID-19, which would limit the transmission of disease.